OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells:: Evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression

被引:71
作者
Kim, MY
Anderson, G
White, A
Jenkinson, E
Arlt, W
Martensson, IL
Erlandsson, L
Lane, PJL
机构
[1] Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Med, Div Med Sci, Birmingham B15 2TT, W Midlands, England
[3] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England
基金
英国医学研究理事会;
关键词
D O I
10.4049/jimmunol.174.11.6686
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this report, we have examined the expression of the T cell survival signals, OX40 ligand (OX40L) and CD30 ligand (CD30L) on CD4(+)CD3(-)CD11c(-)B220(-)IL-7R alpha(+) inducer cells from birth to adulthood in mice. We found that adult but not neonatal inducer cells expressed high levels of OX40L and CD30L, whereas their expression of TNF-related activation-induced cytokine (TRANCE) and receptor activator of NF-kappa B (RANK) was comparable. The failure of neonatal inducer cells to express the ligands that rescue T cells helps to explain why exposure to Ag in neonatal life induces tolerance rather than immunity. The expression of OX40L and CD30L on inducer cells increased gradually in the first few weeks of life achieving essentially normal levels around the time mice were weaned. We found that IL-7 signaling through the common cytokine receptor gamma-chain was critical for the optimal expression of both TNF-related activation-induced cytokine and CD30L but not OX40L. Furthermore, glucocorticoids, which potently suppress T effector function, did not influence the expression of OX40L and CD30L in the presence of IL-7.
引用
收藏
页码:6686 / 6691
页数:6
相关论文
共 28 条
  • [1] Essential role of IL-7 receptor α in the formation of Peyer's patch anlage
    Adachi, S
    Yoshida, H
    Honda, K
    Maki, K
    Saijo, K
    Ikuta, K
    Saito, T
    Nishikawa, S
    [J]. INTERNATIONAL IMMUNOLOGY, 1998, 10 (01) : 1 - 6
  • [2] A chemokine-driven positive feedback loop organizes lymphoid follicles
    Ansel, KM
    Ngo, VN
    Hyman, PL
    Luther, SA
    Förster, R
    Sedgwick, JD
    Browning, JL
    Lipp, M
    Cyster, JG
    [J]. NATURE, 2000, 406 (6793) : 309 - 314
  • [3] ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS
    BILLINGHAM, RE
    BRENT, L
    MEDAWAR, PB
    [J]. NATURE, 1953, 172 (4379) : 603 - 606
  • [4] DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING EXPRESSION OF THE COMMON CYTOKINE RECEPTOR-GAMMA CHAIN
    CAO, XQ
    SHORES, EW
    HULI, J
    ANVER, MR
    KELSALL, BL
    RUSSELL, SM
    DRAGO, J
    NOGUCHI, M
    GRINBERG, A
    BLOOM, ET
    PAUL, WE
    KATZ, SI
    LOVE, PE
    LEONARD, WJ
    [J]. IMMUNITY, 1995, 2 (03) : 223 - 238
  • [5] Chung JY, 2002, J CELL SCI, V115, P679
  • [6] THYMOCYTE DEVELOPMENT IN MAJOR HISTOCOMPATIBILITY COMPLEX-DEFICIENT MICE - EVIDENCE FOR STOCHASTIC COMMITMENT TO THE CD4 AND CD8 LINEAGES
    CRUMP, AL
    GRUSBY, MJ
    GLIMCHER, LH
    CANTOR, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) : 10739 - 10743
  • [7] RANK is essential for osteoclast and lymph node development
    Dougall, WC
    Glaccum, M
    Charrier, K
    Rohrbach, K
    Brasel, K
    De Smedt, T
    Daro, E
    Smith, J
    Tometsko, ME
    Maliszewski, CR
    Armstrong, A
    Shen, V
    Bain, S
    Cosman, D
    Anderson, D
    Morrissey, PJ
    Peschon, JJ
    Schuh, J
    [J]. GENES & DEVELOPMENT, 1999, 13 (18) : 2412 - 2424
  • [8] An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells
    Eberl, G
    Marmon, S
    Sunshine, MJ
    Rennert, PD
    Choi, YW
    Littman, DR
    [J]. NATURE IMMUNOLOGY, 2004, 5 (01) : 64 - 73
  • [9] Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
    Eissner, G
    Kolch, W
    Scheurich, P
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (05) : 353 - 366
  • [10] FACHET J, 1972, CLIN EXP IMMUNOL, V10, P661